Search Results

Enhancing Quality Through Training.

• Authors : Haigney, Susan

Subjects: *SUPPLY chains; *PHARMACEUTICAL industry; *MANUFACTURING industries

• Source: Pharmaceutical Technology Europe. Nov/Dec2024, Vol. 36 Issue 10, p12-15. 4p.

Record details

Wyden Urges DoJ to Release Info On 'Hemisphere' Surveillance.

Subjects: DRUG control; ATTORNEYS general; DRUG administrationWYDEN, Ron, 1949-

• Source: Telecommunications Reports. 12/1/2023, Vol. 89 Issue 21, p11-12. 2p.

Record details

Improvements to EMA's PRIME Designation Scheme: Changes to PRIME scheme are set to drive greater harmonization across major pharmaceutical markets.

• Authors : Piachaud-Moustakis, Bianca

Subjects: *INTERNATIONAL relations; *STRATEGIC planning; *GOVERNMENT regulationUNITED States

• Source: Pharmaceutical Technology Europe. Jul2023, Vol. 35 Issue 7, p7-8. 2p.

Record details

The Power of PK/PD in mAb Development.

• Authors : Mirasol, Feliza

Subjects: DRUG control; BIOLOGICAL products; PHARMACOLOGY

• Source: Pharmaceutical Technology Europe. Dec2022, Vol. 34 Issue 12, p16-17. 2p.

Record details

499.

• Authors : Dick, Jeff T.

Subjects: *DRUG control499 (Film)REYES, Rodrigo

• Source: Library Journal. Aug2022, Vol. 147 Issue 8, p60-60. 1/9p.

Record details

Cannabis rescheduling may boost market, but banking uncertainties loom.

• Authors : Sanneh, Ebrima Santos

Subjects: *BANKING industry; *RISK-taking behavior; DRUG controlUNITED States. Drug Enforcement Administration

• Source: American Banker. 5/7/2024, pN.PAG-N.PAG. 1p.

Record details

US FDA Steps Up cGMP Enforcement for OTC Drugs: Senior managers of OTC drug companies are on a learning curve, as FDA warning letters cite insufficient understanding of cGMPs and inadequate responses to prior 483s.

• Authors : Shanley, Agnes

Subjects: DRUG control; NONPRESCRIPTION drugs; LETTERSUNITED States. Food & Drug Administration

• Source: Pharmaceutical Technology Europe. Aug2019, Vol. 31 Issue 8, p49-50. 2p.

Record details

CANNABIS REMAINS PROBLEMATIC FOR GLAUCOMA: Drawbacks, limited research shadow potential benefits.

• Authors : Harrison, Laird; Radhakrishnan, Sunita

Subjects: *CANNABIS (Genus); *DRUG control; *GLAUCOMAUNITED States

• Source: Ophthalmology Times. 9/1/2017, Vol. 42 Issue 14, p11-12. 2p.

Record details

Converting Injectable Therapies to Combination Drug-Device Products: The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.

• Authors : HÖRBURGER, MARKUS

Subjects: *MARKETING; *SOCIOECONOMIC factors; DRUG delivery systems

• Source: BioPharm International. 2022 Special Issue, p14-17. 3p.

Record details

Pills, Powder, and Smoke: Inside the Bloody War on Drugs.

Subjects: *DRUG control; *PILLS; *POWDERS

• Source: Publishers Weekly. 9/9/2019, Vol. 266 Issue 36, p60-60. 1/6p.

Record details